Cargando…
CD19嵌合抗原受体T细胞治疗病灶大于7.5 cm的复发/难治B细胞淋巴瘤肿瘤局部反应与疗效分析
OBJECTIVE: To observe the local reactions and efficacy of CD19 CAR-T therapy in recurrence/refractory B-cell non-Hodgkin's lymphoma (R/R NHL) patients with >7.5 cm lesions. METHODS: 32 R/R NHL patients with >7.5 cm lesions were enrolled and injected with CD19 CAR-T cells. Flow cytometry w...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408490/ https://www.ncbi.nlm.nih.gov/pubmed/34455744 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.07.007 |
Ejemplares similares
-
嵌合抗原受体T细胞免疫治疗T细胞恶性肿瘤研究进展
Publicado: (2022) -
嵌合抗原受体T细胞治疗儿童复发、难治急性B淋巴细胞白血病48例的长期疗效分析
Publicado: (2019) -
嵌合抗原受体T细胞的结构演变及展望
Publicado: (2020) -
嵌合抗原受体T细胞治疗B细胞淋巴瘤研究进展
Publicado: (2018) -
嵌合抗原受体T细胞相关脑病综合征一例
Publicado: (2020)